©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2014; 20(12): 3180-3190
Published online Mar 28, 2014. doi: 10.3748/wjg.v20.i12.3180
Published online Mar 28, 2014. doi: 10.3748/wjg.v20.i12.3180
Table 1 Platelet abnormalities in inflammatory bowel disease
| Number and morphological changes | Loss of discoid shape |
| Acquisition of pseudopodia | |
| Size increase | |
| Count increase (reactive thrombocytosis) | |
| Density increase | |
| Granular content augmentation | |
| MPV value decrease | |
| PDW value increase | |
| PCT value increase | |
| Other abnormalities | |
| Overproduction and excretion of granular content products | P-selectin, β-TG, PF-4, fibrinogen, vWF, fibrinolytic inhibitors, coagulation, angiogenic and mitogenic factors |
| Increased incorporation of receptors in PLT membrane | CD40, P-selectin, GP53, GP IIb/IIIa, receptors for chemokines, cytokines and complement components |
| Overproduction of PLT-derived microparticles | |
| PLT-PLT aggregates formation | |
| Increased PLT-leukocytes formation |
- Citation: Voudoukis E, Karmiris K, Koutroubakis IE. Multipotent role of platelets in inflammatory bowel diseases: A clinical approach. World J Gastroenterol 2014; 20(12): 3180-3190
- URL: https://www.wjgnet.com/1007-9327/full/v20/i12/3180.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i12.3180